Abstract: Wuchereria brancofti, Brugia malayi, Brugia timori are the main parasites which causes lymphatic filariasis. Lymphatic filariasis is a neglected topical disease with more than 1.3 billoin people worldwide. These are spread from by blood-feeding black flies and mosquitoes. These worms occupy the lymphatic system, including the lymph nodes; in chronic cases, these worms lead to the disease elephantiasis. Filariasis is diagnosed in microfilaraemic cases primarily through direct observation of microfilariae in the peripheral blood. Occult filariasis is diagnosed in amicrofilaraemic cases based on clinical observations and, in some cases, by finding a circulating antigen in the blood.
INTRODUCTION
body parts with associated pain which may progress to Lymphatic filariasis is a parasitic disease caused of worm consists of five stages involving human as by roundworms Wuchereria brancofti, Brugia malayi, definitive host and mosquito as intermediate host and Brugia timori. According to WHO, it is a neglected transmitting vector. The adult stage worms residing in the topical disease with more than 1.3 billion people in lymphatic vessels exhibit sexual dimorphism and male 72 countries worldwide affected and a current infection of worms are shorter in length compared to female worm. 120 million with disfigurement in 40 million people [1] .
Their location in the body varies from species to species Inflammatory reactions initialised by host against adult with brancofti worms predominantly residing in genital stage worm residing in the lymphatic vessels are regions and other species in upper and lower extremities considered to be major contributing factor for the disease [4] . The worms have an average life span of 5 years and occurrence and its subsequent progression to more copulate to produce first stage larva, microfilaria [4] . complex pathology [2, 3] . Typical symptoms of filariasis These circulate in the blood and exhibit periodicity are broadly categorised into asymptomatic, acute and between peripheral and deep vascular circulation in chronic conditions [1] . Asymptomatic stage is the most accordance with the timing of mosquito bite. They are commonly prevailing condition among filarial infected taken up by blood feeding mosquito and further patients with sub-clinical manifestations like microscopic development of microfilariae larvae into infective third hematuria, proteinuria and dilated lymphatics [4] .
stage larvae occurs in the thoracic muscles of mosquito This condition is believed to be driven by over a span of 10-15 days. Transmission of these infective immunoregulatory mechanisms initiated by worms to stage larvae occurs when they are deposited on the lengthen their survival period [3] . Acute conditions surface of skin near punctures caused by blood feeding begins as a result of hosts inflammatory response to the mosquitos, which subsequently migrates into the body death or damage caused to the adult worm where the through these punctures. Infective stage larvae undergo patients suffers from various conditions like high fever, moulting to transform into fourth stage larvae inside the painful inflammation, local transient oedema and human lymphatics. Over a period of 6-9 months, pulmonary eosinophilia [3] . Chronic condition is majorly development of adult worm from this larvae stage occurs characterised by pathological alterations in lymphatics in the central lymphatics and life cycle repeats. The life like hydrocele, lymphoedema resulting in enlargement of cycle of filarial worms is depicted in the figure 1.
more serious condition like elephantiasis [2] . The life cycle 
Chemotherapy in Filariasis:
Drugs currently used in the tested along with other anti-bacterial drugs on wolbachia treatment of lymphatic filariasis in various mass level of insect cell lines which are closely related to wolbachia drug administration level programmes recommended of worms has shown potent activity in reducing the by WHO are diethylcarbazine (DEC), albendazole (ALB), wolbachia levels [8] Later DOX targeting wolbachia in a ivermectin (IVM) [1] . But these drugs had shown action invitro study employing Brugia malayi, was found mainly on infectious stage microfilaria larvae showing potent anti-filaricidal affect by inhibiting (microfilaricidal) thereby halting the transmission and embryogenesis and killing adult worm and microfirae shown poor affect on adult worm (macrofilaricidal) larvae [7] . In this study doxycycline was more potent in which is the major cause of disease [5] .
anti-wolbachial activity compared to other investigated Filarial worms contain an intracellular bacteria antibacterial drugs. Similar results were obtained from wolbachia which was genomically related to other animal studies [11] [12] [13] . The above mentioned animal endosymbiotic wolbachia of arthropod and this made studies along with further genetic studies elucidating their further consideration for investigation in the wolbachia genome has revealed support to bacterium involvement in disease progression and its potential as a as essential for fertility and survival of worm [14] . targeting for chemotherapy [6] [7] [8] [9] . Further their symbiotic Proven more potent in anti-wolbachial action DOX association with filarial worm was supported by study in mechanism of action is based on inhibition of bacterial which tetracycline therapy in murine model of filariasis protein synthesis by binding to the 30S bacterial using L. sigmodontis infected rodents has terminated ribosome and preventing access of amino acyl tRNA to wolbachia and halted the growth and fertility of worm the acceptor (A) site on the mRNA-ribosome complex. [10] . In this study treatment with anti-bacterial drugs that Their preferential action on bacteria is due to their low will not affect rickettsial bacteria (wolbachia) did not affinity for mammalian ribosomes and their inability to affected the worm development in L. sigmodontis and achieve sufficient concentration inside mammalian cells further tetracycline was found to be insensitive to filarae for action [6] .Evaluation of DOX in clinical trials has worm, Acanthocheilonema viteae which don't have demonstrated macrofilaricidal affect evidenced by wolbachia. Doxycycline (DOX), a tetracycline anti-biotic reduction in number of adult worm, their antigenemia and microfilarae larvae [15] [16] [17] . An 8 week course of 200mg/day Drug Delivery for Lymphatic Filariasis: As DOX was doxycycline in human trials has shown significant proved more effective in treating the lymphatic filariasis reduction in microfilaria larvae and macrofilaricidal affects on long term administration, efficient delivery strategies with 51% reduction of pre-treatment antigenemia in blood should be developed for reducing its duration of therapy and 75 % less people having adult worms in scrotal sacs to make it more patience compliance. Delivery systems compared to the placebo at the end of 14 months which release the drugs at sustained rate maintaining the observation period [15] . Similar macrofilaricidal results required concentration of drug for prolonged time in body were observed with reduction in filarial antigenemia can reduce its frequency of administration. In addition as levels by 94% and absence of adult worms from the filarial worms are present inside lymphatic vessels, scrotal region in 89 % of tested people at 24 months after delivery approaches for selective accumulation of DOX at six week regimen of 200 mg/day with four months follow this target site can improve its efficacy and may reduce up administration of 150-200 µg/kg ivermectin and 400 mg the both dose and adverse affects associated with albendazole [16] . Further similar dose studies for 4 and 3 therapy. Nanoparticulates as drug carriers as proven weeks were done with the former study involving from various studies can have the advantage of both administration of ivermectin150 µg/kg after four months of prolonging the life of drug inside the body through starting doxycycline therapy which showed sustaining the drug release for and increasing macrofilaricidal affect approximately similar to that of drug accumulation at specific sites inside the body above 6 week study and later study with administration [24] [25] [26] [27] [28] [29] [30] [31] . Therefore, targeting of DOX loaded of 150-200 µg/kg ivermectin and 400 mg albendazole after nanoparticulates to lymphatic tissues in filariasis may four months of starting therapy showed reduction in improve the disease condition. microfilaraemia with no significant macrofilaricidal Lymphatic targeting for nanoparticulates by activity [17, 18] .These all above studies were done in Sub-cutaneous route (SC) involves two factors: firstly people infected with brancoftian filariasis (caused by it's draining from the site of administration and secondly, Wuchereria brancofti). Recently trials in humans infected their preferential uptake into the lymph nodes [24, 25] . by brugia filariasis were done using 100mg/day for 6
The most investigated route of a nanoparticulates for weeks. In this study microfilaricidal affect were found by lymphatic targeting was SC route it has shown good reduction in microfilarae larvae levels and macrofilaricidal targeting ability and less chance for drug degradation affect was observed by reduction in wolbachia levels at compared to other routes [25, 26] . The nanoparticulate end of 1 year observation [19] . Moreover doxycycline has intended for lymphatic targeting initially must be up shown no severe adverse effects which are associated taken by the lymphatic capillary from interstitial space with conventional anti-filariasis drugs [20, 21] . However when injected S.C..Its uptake depends on both the it needs prolonged therapy for showing anti-wolbachia physiological structure of interstitial space and lymphatic action as observed in above 3 week study [18] which system and upon the physiochemical properties of the lacks significant macrofilaricidal affect and in a nanoparticulates [25] . The ideal size for uptake of colloids study comprising bovine model of onchocerciasis, by S.C administration was between 1-100 nm as the an extra-lymphatic filarial disease in which short regimen ground substance in interstitial space form narrow of Doxycycline (10 mg/kg daily for 14 days) has eliminated aqueous channels of 100 nm diameters through which >60% adult female worms compared to >80% observed they have to passed [32] . However sterically stabilized with long-term treatment (20 mg/kg monthly for 6 months) polymeric nanoparticles of 200 nm poly (lactide-co- [20] . As DOX cannot be recommended for use in mass glycolide) (PLGA) coated with poly (lactide)-poly drug administration programmes due to the cost factor (ethylene glycol) (PLA: PEG) has also shown uptake in long term treatment and its contradiction in children although to a lesser extent into lymphatics [32]. (< 9years) and women [17] , a shorter and safer regimen Similarly, negatively charged surface favours prefential for DOX should be developed for reducing the uptake due to presence of negatively charged duration of therapy and improving the clinical efficacy.
polysaccharide glycosaminoglycan in the interstial A liposomal delivery system for DOX along with other fluid which repels colloids, forcing their uptake [25] . anti-filarial drugs was evaluated for its potential in Finally, hydrophobicity which governs the aggregation treatment of filariasis [22, 23] . The study was concluded and opsonization of nanoparticles may cause aggregation with macrofilaridal affect observed with the combined or interaction of colloids with interstitial space and reduce therapy.
their uptake [25] . This may be the reason for the lesser uptakes of liposomes into lymphatics as these are made of Polymeric of poly (D, L-lactide-co-glycolide) (PLGA) hydrophobic lipids and would have possibly interacted and polycaprolactone (PCL) were selected for the with interstitial space [32] . Lymphatic targeting studies preparation of DOX loaded polymeric nanoparticles. has shown increased uptake for surface modified These polymers are choosen due to their anionic nature, polymeric nanoparticles compared to liposomes when biodegradability in the body, approval by food and drug administered by SC route [24, 27] .In this studies surface administration (FDA), USA [29, 33] . Further studies were modified polymeric nanoparticles of poly (lactide-coreported for use of polymers in the preparation of glycolide) (PLGA) and polystyrene (PS) coated with poly nanoparticles for drug delivery [34, 35] . They are surface (lactide)-poly (ethylene glycol) (PLA: PEG) [25] and PS modified for steric stabilization with adsorption of nanoparticles surface modified with polaxamines and pluronic F-68 on their surface during their preparation. polaxomers [28] have shown higher uptake into They are prepared by solvent displacement method lymphatics. Thus developed nanoparticulates should be reported earlier with minor modification [36] . sufficiently small, hydrophilic, negatively charged and be Nanoparticles were optimized for their size, charge by satirically stabilised so that they can selectively targeted varying the parameters. Optimized nanoparticles was to lymphatic tissues [28] .
evaluated for their in-vitro and in-vivo release pattern. 
Recent Advancement on Lymphatic Filariasis:
properties of interstitial space for its uptake and later in Hawley et al. [25] reported that targeting of colloids by to lymphatic system it will be affected by filtration through lymphatic system involves two stages, firstly its uptake lymph nodes and phagocytosis. Lymphatic function from injection site and secondly its accumulation in the assessment was mentioned using various parameters lymph nodes. The initial uptake of colloids from interstitial like tissue clearance rate, amount of radioactivity per unit space into lymphatic capillaries upon sub-cutaneous time per unit tissue volume, measurement of solute injection depends upon physiology of lymphatic system, concentration ratios between plasma and lymph and local interstitial space and the physiochemical characteristics lymphatic capillary pressures. Finally lymphatic tissue role of colloids. The targeted colloids by SC route due to in cancer metastasis and oedema are explained. limitations imposed by physiology of interstitial space Anil dangi et al.
[23] evaluated liposomes containing and lymphatics should have specified criteria in their doxycycline (DOX) and rifampicin (RFN) administered by physiochemical properties like size, surface charge, sub-cutaneous route along with free oral administration concentration, molecular weight, hydrophobicity for of diethylcarbazine (DEC) for treatment for filariasis. their uptake into lymphatics. Size of the colloids was the The liposomes are formulated for this drug in order to one of the important factors affecting the lymphatic reduce their duration of therapy. The efficacy of the uptake with lowest size in tens of nanometre showing formulation was evaluated in filariasis infected mastomys faster accumulation than large size particles.
with a dose for every 3 days of 10mg/kg for DOX and RFN Concentration of injected colloids has shown inverse 50 mg/kg for DEC. The activity of the formulation was relationship with rate of uptake with higher concentration evaluated by determining the microfilaricidal (microfilariae of colloids showing low rate of uptake. Surface charge larvae killing activity) and macrofilaricidal activity evaluation showed negatively charged colloids showing (adult worm killing activity) in mastomys. Maximal faster uptake compared to positively charged. Molecular microfilaricidal affect 88.1 % on day 20 was observed weight affect on colloids were seen with preferential when liposomal DOX, RFN along with oral lymphatic absorption for MW of > 16000 daltons.
diethylcarbazine was combine administered. Similarly the Hydrophobic colloids have shown reduced up taken into maximum macrofilaricidal affect of 74.8 % at the end of lymphatic system compared to similar colloids which are observation on day 120 was observed with combine hydrophilic due to their surface coating with polaxomers administration of liposomal DOX, RFN and oral DEC. and polaxamines. This affect was due to prevention of
In-vivo release of formulation along with free drug for opsonization of surface modified colloids which will DOX was evaluated in mastomys. The peak prevent phagocytosis. They also emphasized that concentrations for DOX and RFN were found at the end subcutaneous route is the preferred route for lymphatic of 12 h post administration. The formulations showed targeting in which size and hydrophobicity are the sustained release till the end of observation for 48h important factors. Based on earlier reported studies, they maintaining the concentration of DOX and RFN above also mentioned that polymeric nanoparticles may have a their minimum inhibitory concentrations (MIC). The free better chance for targeting compared to liposomes.
form of these drugs when administered maintained Melody [37] described the anatomy, physiology and drug above their MICs for 18 and 6 hours for DOX and biology of the lymphatic system in accordance with RFN. lymphatic drug delivery. Lymphatic system in body helps
Oussoren et al.
[32] explained about the liposomes in transporting lymph which is the excess interstitial fluid for delivering of diagnostic and therapeutic agents back to blood circulation, absorption of essential fats to lymphatic tissues by S.C. route of administration. from intestine and provides immunity to body. It is
The information on lymphatic absorption and lymph organized into different types of vessels with lymphatic node uptake reported by various studies for lymphatic capillaries initially up taking interstitial fluid subsequently targeting of liposomes were mentioned. Factors affecting open into lymph vessels which transport lymph through the liposomes after sub-cutaneous injection such as lymph nodes, trunks and ducts to the circulation. injection site, liposomal size, lipid composition and lipid Lymph is formed when interstitial fluid is up taken into dose were discussed. Influence of surface modification of lymphatic capillaries and it mediated by interstitial fluid liposomes using polyethylene (glycol) (PEG), ligands was pressure and support of the extracellular matrix. Lymph is reported. Finally the review was concluded with propelled in unidirectional way from its vessels by its explanation of the mechanism of localization of liposomes contraction supported by valves along their length.
in regional nodes and therapeutic and diagnostic Solute transport through lymphatic system depends on applications of liposomes.
Moghimi et al. [27] applied the concept of steric more hydrophobic compared to the PLGA nanoparticles. stabilization for examining the lymphatic uptake and Charge density varied by co-precipitating the distribution of sub-cutaneously administered model nanoparticles with different ratios of PLGA terminated polystyrene nanospheres.Block co-polymers of with carboxylic group was used for studying charge polaxamines and polaxomers series are used to produce affect. The results of size affect study showed that the satirically stabilized nanospheres. Their results particles of 50 nm had shown higher concentration of showed an existence correlation between the lengths uptake into initial lymphatic node at 6 h and 48 hrs of stabilizing polyoxyethylene (POE) chains of observation followed by the 100 nm and 200 nm. Similarly block-copolymers and their rate of transport into the serum concentration profile followed similar trend with lymphatic capillaries. Faster particle uptake into lymphatic higher concentration for 50nm. The cumulative capillaries was reported for nanospheres with longer POE accumulation of nodes also showed similar profile. chains and effective opsonization inside lymph nodes Hydrophobicity study using PS nanoparticles showed no was found for nanospheres with POE chains of 5-15 significance difference in the uptake between size 60 nm ethylene oxide units. They observed failure of and 112 nm nanospheres which was believed due to their opsonization if the dimensions of the stabilizing POE aggregation of 60 nm particles occurred by chains exceed the vanderwaals force of attraction and hydrophobicity of particles. Their serum level was found these are rapidly drained into lymphatic capillaries and to be very low compared to PLGA. Charge study showed escaped uptake by macrophages of the regional lymph increased uptake of most anionic particles compared to nodes and even circulated for long time in blood. Finally particles with less anionic charge. This trend was based on their observations they suggested that sterically observed in both lymphatic node and serum uptake. stabilized polymeric nanoparticles may be advantageous Zhang et al.
[31] explained about the application for lymphatic delivery.
of nanotechnology generally of with particle size between Hawley et al. [24] assessed the nanospheres of 1-100 nm in medicine, known as nanomedicine. polystyrene and poly (lactide-co-glycolide) with their Nanomaterial owe their advantage in medicine mainly due surface modified using poly (lactide)-poly (ethylene their unique physiochemical properties like small size, glycol) (PLA-PEG) for lymphatic targeting. Parameters like large surface area and high reactivity in comparison to the the length of PEG chains are varied which affected the size bulk materials of similar composition. These nanoscale and charge of colloids to determine their affect on the systems in medicine can provide more convenient uptake into lymphatic system. Their bio-distribution in route of administration, lower therapeutic toxicity, the body after S.C. administration was evaluated in rats.
extended product life and can reduce the health care The results showed the faster uptakes of surface modified costs. They can be used in therapeutics for controlling nanospheres into lymphatics compared to unmodified the drug release, selective targeting and in diagnosis for nanospheres. The faster uptake was believed to be detection at molecular scale. Advantages of nanoparticles caused by mechanism of steric stabilization due to the in drug delivery are improvement in solubility of poorly reduction of interaction of hydrophilic POE chains with soluble drugs, extension of half-life of drug, minimization the interstitial space forcing the particle uptake. Electron of side effects and timely release of drug inside the body. microscopy study of excised organs revealed the major Nanoparticles particle based therapeutics approved for route of particle uptake was by intercellular spaces clinical use with most of them coming from liposomes and between adjacent endothelial cells of lymphatic capillary. drug conjugates were discussed. Nanoparticles Rao et al. [28] evaluated the lymphatic uptake and therapeutics currently undergoing clinical trials were also lymph node retention of biodegradable nanoparticles of mentioned.These include pegylated, ligand mediated poly (lactide-co-glycolide) (PLGA) by varying their liposomes, drug conjugates, nanoemulsions, dendrimers parameters like sizes, hydrophobicity and surface charge and inorganic nanoparticles. Further nanoparticles which densities by in-vivo studies using rats. Size parameter are in preclinical development consisting of polymeric was evaluated by surface modification with polyethylene nanoparticles, micelles, nanoshells, dendrimers, glycol-co-polylactic acid (PEG-PLA) by co-precipitation engineered viral nanoparticles, albumin based which resulted in nanoparticles of different sizes.
nanoparticles, polysaccharide based nanoparticles, Hydrophobicity affect was evaluated by comparative metallic nanoparticles and ceramic nanoparticles are study using polystyrene (PS) nanoparticles which are covered.
Nutman et al. [4] had briefly discussed about the Hoerauf [5] revived the chemotherapy against history, causative agent, epidemiology, symptoms, onchocerciasis and lymhatic filariasis by mass drug pathology, immunity, diagnosis, treatment along with administration programmes using diethylcarbazine, preventive measures for lymphatic filariasis. The history ivermectin and albendazole. These drugs have shown of filariasis mentioned in the ancient literature along with reduction in spread of infection but failed to controll the the discovery of adult worm larval stages and their life symptoms as these drugs had no or poor affect on adult cycle were mentioned.The five stages in the life-cycle of worm. The ideal profile of drug used for treating filarisis filarial forms in relation to their hosts along with their are given Treatement involving chemotherapy against way of transmission were discussed. The role of wolbachia endosymbionts with doxycycline in clinical wolbachial, endosymbiotic bacteria of filarial worm in trials are mentioned. These trials have shown higher disease progression and worm development are anti-parasitic efficiency and improved disease condition. mentioned. Their epidemiology of filariasis in the Various reccomendations for doxycycline alone or in world accordance with different species of filarial combination with other anti-filarial drugs for treatement in worm, their vectors and symptoms observed were clinical settings are discussed. detailed. The manifestations of the disease in form of
Taylor et al. [9] reviewed the recent studies various symptoms like sub-clinical patent infection, reported by several groups on the structure, acute adenolymphangitis, lymphedema of extremeties distribution and phylogeny of these endosymbionts and genetalia, hydroceles and tropical pulmonary and discussed their role in filarial disease and as a eosinophilia.the pathologiacl and immunological target for chemotherapy. wolbachia location inside mechanisms involved in appearance of symptoms were the body along with its transmission based on explained. Diagnosis based on epidemological history like geneticstudies are explained. wolbachia involvement appearance of lymphodema of the extremeties or genetalia, in biology of arthropods from various studies were physical findings like detection of parasite antigen, DNA, discussed.Affects of various treatements using antiadult worms and laboratoy tests used for detection of biotics on wolbachia are discussed. Finally wolbachia microfilarae on blood smears. antibodies are involvement in pathology and immune response of used.treatement based on chemotherapy and pathology filariasis were discussed. based therapy were mentioned.finally the preventive Sanket et al. [36] prepared polymeric nanoparticles measures for filariasis ucing drugs, pest control and bed of poly (lactide-co-glycolide) (PLGA) containing nets are mentioned.
doxorubicin (DOR) along with nitric oxide donor sodium Dreyer et al. [2] explained pathogenesis of nitoprusside (SNP) for treatment of leishmaniasis. brancoftian filariasis by proposing a model based on the Method used for preparation of nanoparticles was bridging of data from various clinical, parasitological, solvent displacement. Preformulation studies surgical, therapeutic, ultrasonographic and conducted to determine the interaction between DOR histopathological studies.This model is based on the and SNP loaded nanoparticles showed no interaction. explanation of disease condition lymphangiectasia was
The average size of DOX and SNP loaded caused by non-obstructive mechanisms based mainly on nanoparticles was found to be 352 nm with entrapement the ultrasonic data obtained during lymphangiestasia efficiency of 48 % and drug content of 10 % w/w. condition. This model was contrary to traditional threory Biphasic drug release was observed in vitro with an initial which was based on the obstructive mechanisms and burst of DOR and SNP followed by sustained release over immune cell infiltration caused by adult worms 72 hours. responsible for lymphangiestasia condition. This was supported by a study conducted in filariasis infected ACKNOWLEDGEMENT nude mice having no immune components showed lymphangiestasia caused by adult worms. This was All authors thankfully acknowledge, School of further supported by the inflammation present in acute medical and allied sciences, Galgotias university for filarial lymphangitis, a condition followed after providing infrastructure for completing this review. lymphangiestasia caused due to death of adult worms. This was further supported by studies assessing Conflict of Interest: All authors in present review hydrocele and lymphodema of extremeties.
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